Topical For Dogs - Merck Animal Health USA
2014年5月15日 · Bravecto flea control efficacy was evaluated in a 12-week multicenter, clinical field study. 8 Over 12 weeks, there were 3-6x more flea-free dogs with Bravecto than 3 monthly doses of Frontline ® Plus. 14 And, one dose of Bravecto (fluralaner) also reduced fleas by ≥99.8% for 12 weeks. 2,20 The study also found that 86%-100% of dogs with signs attributed …
Bravecto - Merck Animal Health USA
BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS (fluralaner and moxidectin topical solution) for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation.
BRAVECTO® Topical for Cats | Merck Animal Health USA
2014年5月15日 · Bravecto efficacy on killing fleas and stopping flea infestations was evaluated in a 12-week multicenter, clinical field study. 8 Results showed that one dose of Bravecto (fluralaner) reduced fleas by >98% within 12 hours for 12 weeks, 3,8 and acts quickly, with 100% of fleas killed 8 hours after treatment. 3,8 Over 12 weeks of the field study, there were 3-6x more flea …
BRAVECTO® (fluralaner topical solution) for Dogs - Merck Animal …
BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for Cats are for topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS has not been established in breeding, pregnant and lactating cats. All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class. This ...
Fleas Ticks 12 Week Treatment - Merck Animal Health USA
BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS (fluralaner and moxidectin topical solution) for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation.
BRAVECTO® PLUS for Cats | Merck Animal Health USA
BRAVECTO ® PLUS (fluralaner and moxidectin topical solution) for Cats is the solution for fleas, ticks, heartworm and intestinal parasites in ONE easy, 2-month topical. Specifically designed for the challenges of treating cats, BRAVECTO PLUS delivers everything that you expect from BRAVECTO and more.
Bravecto Clinic Resources | Merck Animal Health USA
BRAVECTO Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO is not effective against American dog ticks beyond 8 weeks of dosing.
BRAVECTO 1-MONTH Chews - Merck Animal Health USA
BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS (fluralaner and moxidectin topical solution) for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation.
BRAVECTO® Chews for Dogs | Merck Animal Health USA
BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS (fluralaner and moxidectin topical solution) for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation.
BRAVECTO Chews and Topical Solution for Dogs have not been shown to be effective for 12-weeks' duration in puppies or kittens less than 6 months of age. BRAVECTO Chews and Topical Solution for Dogs are not effective against the lone star tick beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for Cats are